These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Hallucinations during voriconazole therapy: who is at higher risk and could benefit from therapeutic drug monitoring? Pea F; Viale P Ther Drug Monit; 2009 Feb; 31(1):135-6. PubMed ID: 19077926 [No Abstract] [Full Text] [Related]
15. What is the "therapeutic range" for voriconazole? Lewis RE Clin Infect Dis; 2008 Jan; 46(2):212-4. PubMed ID: 18171252 [No Abstract] [Full Text] [Related]
16. Institutional experience with voriconazole compared with liposomal amphotericin B as empiric therapy for febrile neutropenia. Shehab N; DePestel DD; Mackler ER; Collins CD; Welch K; Erba HP Pharmacotherapy; 2007 Jul; 27(7):970-9. PubMed ID: 17594202 [TBL] [Abstract][Full Text] [Related]
17. Voriconazole-associated zygomycosis: a significant consequence of evolving antifungal prophylaxis and immunosuppression practices? Pongas GN; Lewis RE; Samonis G; Kontoyiannis DP Clin Microbiol Infect; 2009 Oct; 15 Suppl 5():93-7. PubMed ID: 19754766 [TBL] [Abstract][Full Text] [Related]
18. Voriconazole-induced retinoid-like photosensitivity in children. Rubenstein M; Levy ML; Metry D Pediatr Dermatol; 2004; 21(6):675-8. PubMed ID: 15575856 [TBL] [Abstract][Full Text] [Related]